VEGFA and diabetic retinopathy: Within the diabetic retinopathy milieu, TL1A expression is initially reduced but surges in advanced stages, possibly mitigating neovascularization by countering the proangiogenic drive of vascular endothelial growth factor (VEGF), even though its protective role may be overshadowed by persistent high VEGF level [65,66].